Request Deal Involvement
AstraZeneca completed the acquisition of Amolyt Pharma from Sofinnova Partners and EQT Life Sciences for $1.05bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Jones Day
financial advisors
Centerview Partners
pr advisors
StrategiesImage
financial advisors
Goldman Sachs
legal advisors
Cooley
pr advisors
LifeSci Partners
pr advisors
Havas
legal advisors
Freshfields Bruckhaus Deringer
or
Principals
target
AMOLYT PHARMA
vendor
SOFINNOVA PARTNERS
vendor
EQT LIFE SCIENCES
bidder
ASTRAZENECA PLC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite